Epinephrine Injection Usp — supply status, manufacturers & alternatives

Epinephrine Injection Usp

ATC A01AD01

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Epinephrine Injection Usp
ATC level 5	A01AD01
ATC level 4	A01AD
Therapeutic category	Auto-created by Health Canada — Recalls and Safety Alerts scraper

Controlled substance	No

Marketing-authorisation holders	PFIZER CANADA ULC, ALVEDA PHARMACEUTICALS INC

Registrations on file	3

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Recalls official enforcement reports

🇨🇦

EPINEPHRINE INJECTION USP

Drugs and health products · July 2025

Class Idetails ↗

🇺🇸

Epinephrine Injection Usp

Hospira Inc. · Oct 2012

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders3 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
EPINEPHRINE INJECTION USP	—	solution	🇨🇦 CA	PFIZER CANADA ULC	Active
Lidocaine Hydrochloride And Epinephrine Injection Usp	—	solution	🇨🇦 CA	PFIZER CANADA ULC	Active
EPINEPHRINE INJECTION USP 1 MG/ML	1 MG	solution	🇨🇦 CA	ALVEDA PHARMACEUTICALS INC	CANCELLED (UNRETURNED ANNUAL)

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.